ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 84 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $227,000 | -55.5% | 43,960 | -63.3% | 0.00% | -55.6% |
| Q2 2021 | $510,000 | -39.9% | 119,750 | -25.0% | 0.01% | -40.0% |
| Q1 2021 | $848,000 | -8.4% | 159,690 | -7.0% | 0.02% | -11.8% |
| Q4 2020 | $926,000 | +12.2% | 171,750 | +66.2% | 0.02% | -32.0% |
| Q3 2020 | $825,000 | +28.3% | 103,335 | +61.0% | 0.02% | -19.4% |
| Q2 2020 | $643,000 | – | 64,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |